Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
CFDA Issues Draft Drug Registration Regulation for Public Comments (with Extensi...
The CFDA issued the draft of a new regulation for drug registration, Provisions for Registration of Drug Products, on July 25 for public comments. Feedbacks are required ... (7/25/2016)
   
NHFPC Releases 2015 Annual Health and Family Planning Sector Development Report (Full Summary) (7/24/2016)
Healthcare Bond Sales Double in Remedy for China Default Panic (7/19/2016)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/2016 (7/19/2016)
The Transformation and Future of China's Biomedical Innovation (7/19/2016)
China's Supreme Court And Supreme Procuratorate Issue Interpretation on Bribery Laws (7/14/2016)
China Issues Guidance Clarifying Core Tasks and Deadlines for Application of The Country's Telemedicine System (7/14/2016)
Pfizer to Use GE's Mobile Biotech Factory to Make Next-Generation Drugs in China (7/12/2016)
Pharmaceutical Trademark Protection in China (7/12/2016)
GE: There Is a Huge Unmet Need for Affordable Biologics in China (7/12/2016)
Can Big Data Cure China's Health Woes? (7/9/2016)
Building A Translational Medicine Powerhouse in China (7/9/2016)
Alibaba Health Re-engineers Business After Setbacks (7/9/2016)
Bloomburg: Chinese Firms Go On Buying Spree for Global Health Assets (7/7/2016)
The Split Mind: China's Preoccupation with Drug Cost Containment and Innovation (7/1/2016)
China's Bid To Be A DNA Superpower (6/22/2016)
CFDA Issues Draft Drug Registration Regu...  (7/25/2016)
MOHRSS: NRDL Revision A Major Task This ...  (7/25/2016)
Upcoming Event: Pharma Business Developm...  (7/22/2016) (free)
Joint Report of World Bank and WHO Call ...  (7/22/2016)
Domestic HPV Vaccine in Final Stage of C...  (7/22/2016)
NHFPC: 24 Provincial Level Governments B...  (7/22/2016)
Jilin Zixin Pharma To Acquire 67% of U.S...  (7/22/2016)
CDE Solicits Comments on the Draft Essen...  (7/21/2016)
ASPEN Pharma Mulls Major Generic Busines...  (7/20/2016)
Sinopharm to Lead in SOE Mixed Ownership...  (7/20/2016)
Performance Review of Top 100 Chinese Ph...  (7/20/2016)
Data Snapshot: Top Ten Listed API, Pharm...  (7/20/2016)
NHFPC Releases Healthcare Statistics for...  (7/20/2016)
Beijing, Tianjin and Hebei Reach Agreeme...  (7/20/2016)
Nine Central Government Agencies Issue D...  (7/20/2016)
Sanofi, Boehringer Ingelheim Agree to Swap Business Asse...
Novartis Splits Pharmaceuticals Division Into Two Busine...
IMS Health Holdings and Quintiles to Combine
Pfizer Abandons Plans to Take Over Allergan Citing New U...
Top 15 Pharma MNCs Experienced Stagnant Performance in 2...
IMS: Review of Chinese CHC Drug Market 2015
New Report: Chinese Vaccine Market Has Much Room for Growth
Data Snapshot: Chinese Hospital Ophthalmology Drug Market 2015
Chinee Animal Vaccine Market Estimated To Have Grown 20.9% in 2...
New Study: Cancer Drugs Least Affordable in India and China
Jilin Zixin Pharma To Acquire 67% of U.S. Genome Firm
ASPEN Pharma Mulls Major Generic Business Expansion in China...
Sinopharm to Lead in SOE Mixed Ownership Reform
Performance Review of Top 100 Chinese Pharmaceutical Compani...
Data Snapshot: Top Ten Listed API, Pharma Formulation and Fo...
CFDA Issues Draft Drug Registration Regulation for Publi...
CDE Solicits Comments on the Draft Essential Principles ...
CFDA Issues Amendment of the Good Supply Practice for Ph...
CFDA Solicits Feedbacks on Draft Rule for Drug Export Sa...
Jiangsu Province Launch New Regulation to Control Drug P...
China's Supreme Court Sides with Local Company in Eli Lilly ...
State Council Introduces New Guidelines for Fair Competition...
China Leads Global Pharma Innovation? By Number of Patent Ap...
USTR Singles Out China's Pharma IP Flaws in 2016 Special 301...
More Details Surface for the Recent GSK Trade Secret Theft C...
Chinese API Industry Revenue Expected to Grow at 9.5% GA...
UK Regenerative Medicine Supplier Expands to China Thru ...
FDA Issues More Warnings Against Chinese API Producers
Dong-A ST Signs Exclusive Deal with Suzhou Sino for Teri...
French Inspectors Uncover Irregularities of Chinese Crud...
Domestic HPV Vaccine in Final Stage of Clinical Trial
Yisheng Biopharma and USAMRIID Announce Positive Animal ...
BeiGene Announces First Patient Dosing in China for BTK ...
Health Care: China's Innovation Hotbed
Chi-Med Global Phase II Trial for Savolitinib
MOHRSS: NRDL Revision A Major Task This Year
Joint Report of World Bank and WHO Call for Deepened Hea...
NHFPC: 24 Provincial Level Governments Began to Facilita...
NHFPC Releases Healthcare Statistics for Q1/2016
Beijing, Tianjin and Hebei Reach Agreement for Joint Dru...
Anhui Drug Regulator Investigated for Corruption
Recent Executive Moves
Recent Executive Moves
Another Senior Health Official Prosecuted
Recent Executive Moves
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma Business Development Course
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links